Ajax-Loading

Eli Lilly and Company - Other Current Liabilities

Eli Lilly and Company's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Other-Current-Liabilities" stands at 24.80 Billion United States Dollars as of 09/30/2025, the highest value at least since 03/31/2011, the period currently displayed.

As of the end of Eli Lilly and Company's third quarter, the item "Other Current Liabilities" stands at 24.80 Billion USD. This represents an increase of 11.40 percent compared to it's value at the end of it's second quarter .


Regarding the One-Year-Change of the series, the current value constitutes an increase of 56.63 percent compared to the value the year prior.
The 1 year change in percent is 56.63.
The 3 year change in percent is 114.93.
The 5 year change in percent is 182.29.
The 10 year change in percent is 286.63.

The Serie's long term average value is 9.04 Billion United States Dollars. It's latest available value, on 09/30/2025, is 174.32 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 12/31/2018, to it's latest available value, on 09/30/2025, is +808.64%.
The Serie's change in percent from it's maximum value, on 09/30/2025, to it's latest available value, on 09/30/2025, is 0.0%.

Other Current Liabilities for Related Companies:

LogoNameMarket Cap (USD)
LogoJohnson & Johnson - Other Current Liabilities486,508,953,600.00
LogoAbbVie Inc - Other Current Liabilities399,570,305,024.00
LogoRoche Holding AG - Other Current Liabilities317,433,206,677.55
LogoAstraZeneca PLC - Other Current Liabilities280,205,508,085.11
LogoNovartis AG - Other Current Liabilities255,096,620,580.91